Login

Kuvera interviews Rahul Singh, Chief Investment Officer - Equities at Tata Asset Management, about Multi Cap Funds.|Gaurav Rastogi is the CEO of Kuvera 00:10:00

Share On Facebook Share On Twitter

Gaurav Rastogi is the CEO of Kuvera

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Exploring Family Zone: Unlocking Key Features for Child Online Safety | Tim Levy, CEO of Family Zone Cyber Safety Ltd
00:10:00
Open Talk with Camilo Marcantonio: Insights from the Founder and Manager of Charles River Capital | Camilo Marcantonio - Founding Partner and CIO at Charles River Capital.
00:10:00
Key Drivers of Interest in Infrastructure Secondaries with Janice Ince | Janice Ince, Managing Director, Pantheon Ventures.
00:10:00
Scott Walker Discusses Wisconsin's Approach to Obamacare and Medicaid
00:10:00
Desjardins Group's Strong Performance and Commitment to Social Responsibility | Guy Cormier, CEO ,   Desjardins Group.
00:10:00
The Growth Engine: A Systematic Approach to User Acquisition|Brian Balfour,Venture Partner,Long Journey Ventures
00:10:00
Revolutionizing Genetic Research Through Consumer Empowerment and Participation|Anne Wojcicki, CEO, 23andme holding co.
00:10:00
Data infra and dev tools specialist fund wo making a difference|Timothy Chen,Managing Partner,Essence VC
00:10:00
Steffen Meister's Keynote Address: Private Markets as the New Investment Norm | Steffen Meister, Chairman, Partners Group .
00:10:00
Leveraging Storytelling for Med Spa Success in a Competitive Market.
00:10:00
Understanding Financial Intimacy: Insights from Ed Comes on Money and Relationships
00:10:00
Understanding Market Cycles: Ignacio Olave and Javier Barrio on Strategic Investments in Cyclical Companies with Azvalor

© 2017 - Neuhu+